Bristol Myers wins latest test for Krazati (NYSE:BMY)
hapabapa/iStock Editorial via Getty Images Bristol-Myers Squibb (New York Stock Exchange:BMY) announced Saturday that its FDA-cleared cancer therapy Krazati (adagrasib), ...
hapabapa/iStock Editorial via Getty Images Bristol-Myers Squibb (New York Stock Exchange:BMY) announced Saturday that its FDA-cleared cancer therapy Krazati (adagrasib), ...
hapabapa/iStock Editorial via Getty Images Bristol-Myers Squibb (New York Stock Exchange:BMY) announced Saturday that its experimental schizophrenia therapy KarXT, acquired ...
RayzeBio shares nearly doubled in early trading Tuesday after the cancer drug specialists agreed to a $4.1 billion acquisition by ...
join our Telegram channel to stay up to date on breaking news coverage Jesse Myers, the hedge fund manager at ...